Improved approach for proteochemometrics modeling: application to organic compound - amine G protein-coupled receptor interactions

MOTIVATION Proteochemometrics is a novel technology for the analysis of interactions of series of proteins with series of ligands. We have here customized it for analysis of large datasets and evaluated it for the modeling of the interaction of psychoactive organic amines with all the five known families of amine G protein-coupled receptors (GPCRs). RESULTS The model exploited data for the binding of 22 compounds to 31 amine GPCRs, correlating chemical descriptions and cross-descriptions of compounds and receptors to binding affinity using a novel strategy. A highly valid model (q2 = 0.76) was obtained which was further validated by external predictions using data for 10 other entirely independent compounds, yielding the high q2ext = 0.67. Interpretation of the model reveals molecular interactions that govern psychoactive organic amines overall affinity for amine GPCRs, as well as their selectivity for particular amine GPCRs. The new modeling procedure allows us to obtain fully interpretable proteochemometrics models using essentially unlimited number of ligand and protein descriptors.

[1]  S. Wold,et al.  New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. , 1998, Journal of medicinal chemistry.

[2]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[3]  Peteris Prusis,et al.  Proteochemometric Mapping of the Interaction of Organic Compounds with Melanocortin Receptor Subtypes , 2005, Molecular Pharmacology.

[4]  Ferran Sanz,et al.  Incorporating molecular shape into the alignment-free Grid-Independent Descriptors. , 2004, Journal of medicinal chemistry.

[5]  Edgar Jacoby,et al.  A Three Binding Site Hypothesis for the Interaction of Ligands with Monoamine G Protein‐coupled Receptors: Implications for Combinatorial Ligand Design , 1999 .

[6]  T. Lundstedt,et al.  Classification of G‐protein coupled receptors by alignment‐independent extraction of principal chemical properties of primary amino acid sequences , 2002, Protein science : a publication of the Protein Society.

[7]  C. Humblet,et al.  G-Protein coupled receptors: models, mutagenesis, and drug design. , 1998, Journal of medicinal chemistry.

[8]  Peteris Prusis,et al.  Proteochemometrics: A Tool for Modeling the Molecular Interaction Space , 2005 .

[9]  Han van de Waterbeemd,et al.  Chemometric methods in molecular design , 1995 .

[10]  M. Reed,et al.  Mechanism of Electron Conduction in Self‐Assembled Alkanethiol Monolayer Devices , 2003, Annals of the New York Academy of Sciences.

[11]  Erik Johansson,et al.  Multivariate design and modeling in QSAR , 1996 .

[12]  T. Lundstedt,et al.  PLS modeling of chimeric MS04/MSH-peptide and MC1/MC3-receptor interactions reveals a novel method for the analysis of ligand-receptor interactions. , 2001, Biochimica et biophysica acta.

[13]  B. Kowalski,et al.  Partial least-squares regression: a tutorial , 1986 .

[14]  G. Cruciani,et al.  Generating Optimal Linear PLS Estimations (GOLPE): An Advanced Chemometric Tool for Handling 3D‐QSAR Problems , 1993 .

[15]  S. Pickett,et al.  GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.

[16]  Paul Geladi,et al.  Principal Component Analysis , 1987, Comprehensive Chemometrics.

[17]  T. Lundstedt,et al.  Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. , 2002, Molecular pharmacology.

[18]  T. Lundstedt,et al.  Proteo-chemometrics analysis of MSH peptide binding to melanocortin receptors. , 2002, Protein engineering.

[19]  T. Lundstedt,et al.  Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. , 2001, Biochimica et biophysica acta.

[20]  Hugo Kubinyi,et al.  Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective , 2004 .

[21]  Gerhard Klebe,et al.  Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures , 1994, J. Chem. Inf. Comput. Sci..

[22]  Mika A. Kastenholz,et al.  GRID/CPCA: a new computational tool to design selective ligands. , 2000, Journal of medicinal chemistry.

[23]  P. Prusis,et al.  Melanocortin Receptors: Ligands and Proteochemometrics Modeling , 2003, Annals of the New York Academy of Sciences.